What are the obligations of pharmaceutical companies in a global health emergency?

10.1016/S0140-6736(21)01378-7

Saved in:

Bibliographic Details
Main Authors:	Emanuel, EJ, Buchanan, A, Chan, SY, Fabre, C, Halliday, D, Heath, J, Herzog, L, Leland, RJ, McCoy, MS, Norheim, OF, Saenz, C, Schaefer, GO, Tan, KC, Wellman, CH, Wolff, J, Persad, G
Other Authors:	DEAN'S OFFICE (MEDICINE)
Format:	Review
Published:	Elsevier BV 2022
Subjects:	Costs and Cost Analysis Developing Countries Drug Industry Global Health Humans Social Responsibility
Online Access:	https://scholarbank.nus.edu.sg/handle/10635/228267
Tags:	Add Tag No Tags, Be the first to tag this record!
Institution:	National University of Singapore

Description
Summary:	10.1016/S0140-6736(21)01378-7

Similar Items